🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is determining the maximum tolerated dose and safety of SU011248...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-07
Trial ID
NCT00712504
This study is designed to determine the clinical efficacy and toxicity of A...
Status
Completed
Location
Site Reference ID/Investigator# 7193
Start Date
2007-06
Trial ID
NCT00486538
Treatments Being Tested
Preclinical studies as well as phase I and II trials have demonstrated that...
Status
Terminated
Location
Cliniques Universiatires St LUC UCL
Start Date
2007-02
Trial ID
NCT00408252
This study is a multicenter, open-label, randomized controlled trial that e...
Status
Not Yet Recruiting
Location
Peking University Cancer Hospital
Start Date
2025-09-25
Trial ID
NCT07165418
Treatments Being Tested
The purpose of this study is to find out if SU011248 works and if it is saf...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2008-04
Trial ID
NCT00578526
The purpose of this study is to evaluate the combination of Pegylated Alfa ...
Status
Terminated
Location
Baylor College of Medicine - Methodist Hospital
Start Date
2007-05
Trial ID
NCT00522249
Treatments Being Tested
The purpose of this study is to test the effect of the combination of sunit...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2008-02
Trial ID
NCT00720148
Treatments Being Tested
VHL patients may benefit from sunitinib. This study will investigate the fo...
Status
Completed
Location
Hospital Saint André - Service de cancérologie
Start Date
2010-03
Trial ID
NCT01168440
Treatments Being Tested
To compare treatment with SU011248 plus paclitaxel versus bevacizumab plus ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-11
Trial ID
NCT00373256
Treatments Being Tested
This was a randomized, open label, parallel group, Phase II study to evalua...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-05-19
Trial ID
NCT01147822